These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 7295047

  • 1. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
    Catapano AL, Capurso A, Kinnunen PK.
    Artery; 1981; 9(2):87-95. PubMed ID: 7295047
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 3. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ, Breckenridge WC.
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [Abstract] [Full Text] [Related]

  • 4. [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].
    Dergunov AD, Shuvaev VV, Perova NV.
    Biokhimiia; 1990 Jan; 55(1):134-46. PubMed ID: 2160840
    [Abstract] [Full Text] [Related]

  • 5. In vitro transfer of apolipoproteins from plasma lipoproteins to artificial lipid particles.
    Asami H, Iriyama K.
    Nutrition; 1990 Jan; 6(2):143-5. PubMed ID: 2134526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Apoprotein metabolism in human obesity.
    Nestel PJ.
    Int J Obes; 1982 Jan; 6 Suppl 1():105-9. PubMed ID: 7118365
    [Abstract] [Full Text] [Related]

  • 8. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V, Beyne P, Frommherz K, Roullet JB, Drüeke T.
    Ann Biol Clin (Paris); 1989 Jan; 47(8):497-501. PubMed ID: 2690681
    [Abstract] [Full Text] [Related]

  • 9. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G.
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [Abstract] [Full Text] [Related]

  • 10. [Studies on duck serum lipoproteins. VIII. Studies on biological activity and metabolism of HDL-apo C II in vitro].
    Li XZ, Wang KQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):89-94. PubMed ID: 2955931
    [No Abstract] [Full Text] [Related]

  • 11. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L, Berg G, Zago V, Gonzalez AI, Wikinski R.
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL.
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
    Stalenhoef AF, Malloy MJ, Kane JP, Havel RJ.
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1839-43. PubMed ID: 6584917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of insulin in lipoprotein secretion by cultured rat hepatocytes.
    Patsch W, Franz S, Schonfeld G.
    J Clin Invest; 1983 May; 71(5):1161-74. PubMed ID: 6343434
    [Abstract] [Full Text] [Related]

  • 16. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P, Wang CS, McConathy WJ, Weiser D, Downs D.
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [Abstract] [Full Text] [Related]

  • 19. Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
    Lambert DA, Catapano AL, Smith LC, Sparrow JT, Gotto AM.
    Atherosclerosis; 1996 Dec 20; 127(2):205-12. PubMed ID: 9125310
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K, Fitzharris TJ, Shinomiya M, Muntz HG, Harmony JA, Jackson RL, Quinn DM.
    J Lipid Res; 1983 Jun 20; 24(6):721-30. PubMed ID: 6688442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.